Why Cell-Free RNA Is the Future of Liquid Biopsy

Liquid biopsy has long promised a future where a simple blood draw can reveal deep insights about human health. While circulating tumor DNA (ctDNA) has dominated the field, cell-free RNA (cfRNA) is emerging as a far richer source of biological information.

Beyond DNA: The Dynamic Transcriptome

Unlike DNA, which is largely static, RNA reflects the dynamic state of cells and tissues in real time. Cell-free RNA circulating in blood plasma carries signals from every organ system — a molecular snapshot of health and disease.

A single blood draw yields over 20,000 expression values spanning the entire transcriptome. This richness enables detection of subtle biological changes long before they manifest as clinical symptoms.

The Challenge: Making Sense of Complexity

cfRNA data is inherently challenging: extreme sparsity, heavy-tailed distributions, and complex correlation structures make traditional analysis methods inadequate. This is where AI becomes essential.

At Eigen Bio, we've developed foundation models specifically designed for cfRNA's unique statistical properties. By training on biologically grounded synthetic data, our models learn inductive biases that match the geometry of real cfRNA.

The Road Ahead

As cfRNA-based diagnostics mature, we expect to see transformative applications across oncology, immunology, maternal-fetal health, and beyond. The transcriptome is the most information-rich window into human biology we've ever had — and we're just beginning to learn how to read it.